NEWS
Mar 11, 2026

SSRP Institute Announces Troscriptions as New Trusted Partner 

PARTNER ANNOUNCEMENT

WILLOUGHBY, Ohio, [Mar 11, 2026] — The SSRP Institute today announced the addition of Troscriptions as its newest Trusted Partner, following nomination by SSRP Fellow Dr. Elizabeth Yurth and upon completion of the organization’s internal clinical review and vetting process.

Troscriptions offers physician-formulated, pharmaceutical grade, precision-dosed health optimization formulations delivered through a buccal troche. This new partnership reflects SSRP’s ongoing commitment to connecting providers with companies aligned with its education-first mission and standards of scientific integrity within cellular medicine.

“This partnership makes sense because both organizations are laser-focused on helping clinicians practice with precision tools that make a real clinical impact,” said Dr. Scott Sherr, Chief Medical and Health Education Officer of Troscriptions. 

“Trusted Partners are selected because they bring real-world clinical value to our Community,” said Matthew Seeds, CEO at SSRP. “Our Members rely on us to maintain a network built on experience, thoughtful evaluation, and shared educational principles. We are excited to welcome Troscriptions into that ecosystem.”

The new Trusted Partner page for Troscriptions is now live on the SSRP website and serves as a centralized resource for Members and providers seeking additional information about the company, its mission, and its role in supporting clinical implementation.

Dr. Yurth, who nominated Troscriptions for consideration, shared that alignment in scientific philosophy and clinical usefulness made the partnership a natural fit for the SSRP Community. “Troscriptions stands out for their commitment to innovation, education, and supporting practitioners in the longevity and regenerative medicine space. Their platform and community have been invaluable for connecting like-minded clinicians and advancing the field. I’m proud to see them recognized by SSRP.” 

Through these partnerships, the SSRP aims to support providers by connecting them with vetted resources that complement training, protocol development, and implementation in practice.

For more information and to view the Troscriptions Partner Page, visit:
SSRP Troscriptions Partner Page


About the SSRP Institute

The SSRP Institute is an education-focused organization dedicated to advancing cellular medicine through evidence-based training, professional collaboration, and clinically relevant research. SSRP supports providers worldwide through certifications, events, and ongoing educational programming designed to improve patient outcomes and elevate the standard of care.

The Trusted Partner Network is invitation-only and based on real clinical application within the SSRP ecosystem. Companies are nominated by SSRP Members and undergo a vetting process designed to ensure alignment with SSRP’s educational standards and patient-centered approach. There are no pay-to-play arrangements, promotional contracts, or commission structures tied to inclusion in the network. 

RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
VIDEO
Cellular Medicine Mondays
Apr 27, 2026
Ep. 085 - Peptide Pharmacokinetics
Preview Only
Dissecting Protocols – Episode 085

Peptide Pharmacokinetics

Dissecting Protocols, Dr. Seeds breaks down the reasoning behind SubQ vs. IM peptide administration. From pharmacokinetic considerations to the growing misuse of combining peptides with oil-based medications in the same syringe, this discussion helps clarify proper application and safety considerations.

Preview Only — Become a member for full access
ARTICLE
William Seeds, MD
Apr 21, 2026
A Review of Circadian Processes and Evidence-Based Interventions to Improve Sleep
William Seeds, MD Apr 21, 2026
A Review of Circadian Processes and Evidence-Based Interventions to Improve Sleep
Introduction In March of this year, I did a Rabbit Hole (Episode 079) in which I discussed a number of trends marketed to the wider public promising sleep improvement. As you know, a huge swath of the population suffers from sleep disturbance. According to the NIH, approximately 30% to 40% of US adults report sleep […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
Apr 20, 2026
Ep. 084 - The Cellular Impact of UVA vs. UVB Light (Part 2)
Preview Only
Rabbit Holes – Episode 084

The Cellular Impact of UVA vs. UVB Light (Part 2)

Dr. Seeds continues this Rabbit Hole on UVA vs. UVB light in Part 2, covering oxidative stress, skin aging, vitamin D synthesis, and the risks of tanning beds. A helpful look at why not all UV exposure works the same, why that distinction matters, and how it shapes both skin health and cellular function

Catch Part 1 (Rabbit Holes – Ep. 081) HERE

Preview Only — Become a member for full access
SSRP Institute Apr 15, 2026
FDA Announces Change in Status of 12 Peptides
BREAKING NEWS APRIL 15, 2026 – In a welcome announcement to the SSRP community, the FDA reported today that it will imminently remove the following bulk drug substances from category 2: BPC-157, LL-37, DiHexa, DSIP, Epitalon, *GHK-Cu (injectable only), KPV, PEG-MGF, Melanotan II, MOTs-C, Semax, and TB-500. Originally nominated for Category 2 (Bulk Substances that […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Apr 13, 2026
Ep. 083 - Safety of Low-Dose Oral Minoxidil for Hair Loss: A Multicenter Study of 1404 Patients
Preview Only
Journal Club – Episode 083

Safety of Low-Dose Oral Minoxidil for Hair Loss: A Multicenter Study of 1404 Patients

Dr. Seeds discusses this article on low dose minoxidil for hair loss and shares why a lower, slower dosing approach may lead to better outcomes. He also reviews key safety considerations, side effects, and practical dosing insights for both men and women. (Article Link)

Preview Only — Become a member for full access
SSRP Institute Apr 9, 2026
SSRP Institute Welcomes StemWave as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [April 9, 2026] — The SSRP Institute announces that StemWave has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process. StemWave provides an FDA-listed, non-invasive acoustic wave therapy platform used in musculoskeletal care. The technology delivers focused mechanical energy to targeted tissues, supporting improved circulation, […]
READ NEWS
Mastermind Mastermind
Mastermind 15: The Aesthetic Matrix
This course teaches a mechanism-informed approach to aesthetic skin aging by connecting environmental exposures and procedures with cellular stress, inflammation, and repair biology. You’ll review how UVA and UVB contribute to photoaging, how visible/blue light is discussed in pigmentation and...
10 Lessons
17 hrs 24 min
View Course
VIDEO
Cellular Medicine Mondays
Mar 30, 2026
Ep. 081 - The Cellular Impact of UVA vs. UVB Light (Part 1)
Preview Only
Rabbit Holes – Episode 081

The Cellular Impact of UVA vs. UVB Light (Part 1)

In this Rabbit Holes episode, Dr. Seeds explains the mechanistic differences between UVA and UVB light, highlighting how each spectrum uniquely contributes to photoaging, oxidative stress, DNA damage, and skin cancer risk. He also outlines cellular strategies to support antioxidant defenses, mitochondrial function, and DNA repair in response to chronic light exposure.

Want to learn more? Check out Mastermind 15 on Aesthetics!

Preview Only — Become a member for full access
Medivive Mar 27, 2026
SSRP Institute Welcomes Medivive as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [March 27, 2026] — The SSRP Institute is pleased to announce that Medivive has joined its Trusted Partner Network following nomination and internal vetting aligned with SSRP’s mission of advancing science-first, education-driven clinical collaboration. Medivive offers an advanced approach to NAD⁺ therapy designed to support cellular energetics through sterile, clinician-prescribed formulations […]
READ NEWS

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.